Pharmaceuticals

H1N1 Vaccine Industry Insights: Market Forecast to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The H1N1 Vaccine Market Size Likely To Evolve From 2025 Through 2034?

The H1N1 vaccine market has demonstrated robust growth in its size over recent years. It is projected to expand from $3.33 billion in 2024 to $3.52 billion in 2025, at a compound annual growth rate (CAGR) of 5.7%. The historical increase can be attributed to factors such as previous influenza outbreaks, global health security concerns, the efficacy of vaccine development and approval processes, widespread global vaccination campaigns, various public health education initiatives, substantial government funding and subsidies, and the inherent agility of the pharmaceutical industry.

The H1N1 vaccine market is projected to experience robust expansion over the coming years, with expectations to reach “$4.69 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.4%. This anticipated growth during the forecast period is attributable to ongoing research into broad-spectrum vaccines, worldwide initiatives promoting vaccine equity, efforts to strengthen public health resilience, the reinforcement of global health governance, and the integration of H1N1 vaccination into routine immunization programs. Prominent trends for the forecast period include global pandemic preparedness, various influenza vaccination initiatives, significant advancements in vaccine development, focused research on cross-protection, overarching global health programs, technological improvements in vaccine manufacturing processes, expanded production capacities, and enhanced data monitoring and surveillance systems.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7881&type=smp

Which Drivers Are Supporting Growth Of The H1N1 Vaccine Market?

Increased investment in research and development activities within immunology and vaccine fields is projected to advance the H1N1 vaccine market. Immunology and vaccines serve to prevent infections and facilitate the body’s production of antibodies to combat diseases. Immunology, in particular, stands as a critical area of research in medical and biological sciences, focusing on understanding the immune system. The H1N1 vaccine is a preparation designed to boost antibody generation, thereby offering protection against various illnesses. For example, in March 2023, the US-based National Institutes of Health (NIH) indicated that research supported by the NIH played a key role in the swift development of mRNA COVID-19 vaccines. By March 2022, over 577 million doses had been administered in the United States, estimated to have saved 2.4 million lives and prevented 17 million hospitalizations. Thus, the growing expenditure on research and development efforts in immunology and vaccines is a primary driver for the expansion of the H1N1 vaccine market.

What Are The Major Segments Identified In The H1N1 Vaccine Market?

The h1n1 vaccine market covered in this report is segmented –

1) By Product Type: Inactivated Vaccine, Live Attenuated Vaccine

2) By Route Of Administration: Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination

3) By End Users: Hospitals, Clinics, Research And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Inactivated Vaccine: Injectable Inactivated Vaccine, Intranasal Inactivated Vaccine

2) By Live Attenuated Vaccine: Injectable Live Attenuated Vaccine, Intranasal Live Attenuated Vaccine

What Are The Major Trends Driving The Growth Of The H1N1 Vaccine Market?

Strategic collaborations among companies represent a significant and growing trend within the H1N1 (swine flu) vaccination market. Businesses in the H1N1 (swine flu) Vaccination market are concentrating on strategic alliances to expand their market share. For instance, in August 2022, a prominent pharmaceutical company and hVIVO, an Open Orphan affiliate, reached an agreement valued at $123 million to develop a new batch of H1N1 influenza challenge virus. This initiative has invigorated the growth potential for both companies within the industry.

Which Major Firms Are Strengthening Their Position In The H1N1 Vaccine Industry?

Major companies operating in the H1N1 vaccine market are Sanofi SA, GlaxoSmithKline PLC, CSL Limited, AstraZeneca Inc., Zydus Lifesciences Limited, Merck and Co.Inc., Novavax Inc., Panacea Biotec Ltd., Sinovac Biotech Ltd., Green Cross Corp., Pfizer Inc., Seqirus Ltd., Cipla Inc., Protein Sciences Corporation, Hualan Biological Engineering Inc., Changsheng Bio-Technology Co. Ltd., Bharat Biotech International Limited, Serum Institute of India Pvt. Ltd., Bio Farma Group, PT Kalbe Farma Tbk, Moderna Inc., CureVac NV, BioNTech SE, Inovio Pharmaceuticals Inc., Vaxart Inc., Altimmune Inc., Dynavax Technologies Corporation, VBI Vaccines Inc., GeoVax Labs Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/h1n1-vaccine-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The H1N1 Vaccine Market?

North America was the largest region in the H1N1 vaccine market in 2024. The regions covered in the H1N1 vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The H1N1 Vaccine Market Report:

https://www.thebusinessresearchcompany.com/customise?id=7881&type=smp

Browse Through More Reports Similar to the Global H1N1 Vaccine Market 2025, By The Business Research Company

Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Pediatric Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Veterinary Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795